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Abstract
Background: We compared the risk of being diagnosed with smoking-related cancers (lung, oral cavity, upper
digestive and respiratory organs, bladder, kidney, anogenital cancers and myeloid leukaemia) among people with
squamous cell carcinoma (SCC) or basal cell carcinoma of the skin (BCC), with risks found in the general population
using data from an Australian population-based cancer registry.
Methods: People diagnosed with BCC or SCC in 1980-2003 reported to the Tasmanian Cancer Registry, Australia,
were followed-up by linkage within the registry, until diagnosis of a subsequent smoking-related cancer, death, or
until 31 December 2003. Risk of developing a future smoking-related cancer was assessed using age Standardised
Incidence Ratios (SIR).
Results: People diagnosed with SCC had an increased risk of lung cancer (men: SIR = 1.89, 95% confidence
interval: 1.61-2.21; women: SIR = 2.04, 1.42-2.83) and all other smoking-related cancers (men: SIR = 1.38, 1.19-1.60;
women: SIR = 1.78, 1.34-2.33). Men with BCC had a significant increased risk of lung cancer (SIR = 1.26, 1.10-1.44)
but not of any of the other smoking-related cancers (SIR = 1.09, 0.97-1.23).
Conclusions: Individuals with a history of SCC having an increased risk of developing smoking related cancers
cancer suggests smoking as a common etiology. The relationship between BCC and smoking-related cancers is less
certain.
Background
Non-melanoma skin cancer (NMSC) is the most com-
mon cancer in Australia, with an estimated 374,000 new
cases in 2002 [1], comprising 32% squamous cell carci-
noma (SCC) and 68% basal cell carcinoma (BCC).
Although exposure to sunlight is regarded as the most
important risk factor for the majority of NMSC, the role
of smoking in the etiology of these cancers, especially
SCC has been unclear. There is some biological plausi-
bility for this association, because certain tar by-pro-
ducts of smoking have been known since the early 20th
century to cause skin cancers in experimental animals
and humans [2].
It is well established that tobacco smoking is causally
related to a number of squamous cell cancer subtypes in
several internal organs including those of the oral cavity,
oesophagus, lung, bladder and cervix [3]. With respect
to the skin, it is inconclusive whether smoking is also
related to SCC [4]. The relationship between smoking
and risk of SCC has been found in a number of case
control [5,6] and cohort studies [7,8], but no association
was found between smoking and BCC [6,7]. Current
smokers, compared with never smokers, were at a
higher risk of SCC with odds ratios (or relative risks)
ranging from 2.9 to 3.9 in different populations [5-7]. If
smoking is associated with an increased risk of SCC,
then it would be expected that those with SCC would
be at a higher risk of lung and other tobacco associated
cancers. Despite a number of studies in a systematic
review supporting this association [9], others found that
history of a previous diagnosis of SCC was associated
with a reduced risk of subsequent cancer including
some smoking-related cancers [10,11]. The possible rea-
sons for these differences are varied and unclear. Hence
the epidemiological evidence of an association between
a previous diagnosis of SCC and a subsequent smoking-
related cancer remains unclear.
* Correspondence: freddys@nswcc.org.au
1Cancer Research Division, Cancer Council New South Wales, Sydney,
Australia
Full list of author information is available at the end of the article
Sitas et al. BMC Research Notes 2011, 4:556
http://www.biomedcentral.com/1756-0500/4/556
© 2011 Sitas et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.In this study, we compared the risk of developing a
future smoking-related cancer among people with SCC
and BCC with that of the general population of Tasma-
nia, Australia. The population-based Tasmanian Cancer
Registry (TCR) is one of the few registries worldwide
that collects information on histologically confirmed
NMSC. The availability of these data and other incident
primary cancers from the TCR provided us a unique
opportunity to assess whether people with either SCC
or BCC have an excess risk of lung and other smoking-
related cancers.
Methods
Study population
Tasmania is an island State which lies south of the
mainland of Australia, between latitudes 40 and 43
degrees south with a uniform moderate ultraviolet (UV)
index across the island of around 5 http://www.bom.
gov.au/jsp/ncc/climate_averages/uv-index/index.jsp, and
corresponding homogeneous melanoma incidence rates
[12]. It has a population of approximately 460,670 peo-
ple in 2001 [13], predominantly of Caucasian origin. By
statutory regulation the TCR (established in 1977)
receives compulsory cancer notifications from all Tas-
manian pathology laboratories and also notifications
from pathology laboratories of other Australian States
and Territories if people have been identified as Tasma-
nian residents [14]. Cancer notifications are also sup-
plied by the two radiation oncology clinics and private
and public hospitals in Tasmania [14]. The TCR gener-
ally has high standards of data completeness, quality
and follow-up, with over 80% of lung cancers verified
microscopically; the data are accepted by the Interna-
tional Agency for Research on Cancer for publication in
Cancer Incidence in Five Continents [14]. The TCR is
the only population-based registry in Australia that
records histologically confirmed NMSC, mainly BCC
and SCC [15]. All people aged 40-74 years diagnosed
with BCC or SCC reported to the TCR between 1980
and 2003 were followed-up, by record-linkage, until
diagnosis of a subsequent lung cancer (C33-C34) or
other smoking related cancer, death, or 31 December
2003. Other smoking-related cancers are those defined
by IARC in 2004: the oral cavity (C01-C06, C09), upper
digestive (C15, C16, C22, C25) and respiratory organs
(C10-C14, C32), bladder (C67), kidney (C64-C65), ano-
genital cancers (C21, C51-C53, C60), and myeloid leu-
kaemia (C42) [3]. Age standardised (world) lung cancer
incidence rates are 35 per 100,000 for males and 21 per
100,000 for females, all the other smoking related can-
cers are rarer [14]. The study was approved by the
Human Research Ethics Committee (Tasmania)
Network.
Statistical analysis
To calculate person-years at risk for the cohort of BCC
or SCC cases, the time-at-risk started at the first BCC
or SCC diagnosis in or after 1980 and ended at the diag-
nosis of the first primary smoking-related cancer, death
or the end of 2003, whichever occurred first. Deaths in
the cohort were determined by linkage with records
from the Registry of Births, Deaths and Marriages and
the National Death Index [16]. Age, sex and period-spe-
cific cancer incidence rates in Tasmania were used to
calculate the expected numbers of lung or other smok-
ing-related cancers in those with BCC or SCC. The
Standardised Incidence Ratio (SIR) was calculated as the
ratio of the observed to the expected numbers of people
with a previous diagnosis of BCC or SCC who had a
subsequent smoking-related cancer. A 95% confidence
interval (CI) for the SIR was calculated by assuming a
Poisson distribution for the observed number of people
with smoking-related cancers among those with BCC or
SCC [17]. Absolute excess risk (AER) of a subsequent
smoking-related cancer was also calculated by subtract-
ing the expected number of cases in the general popula-
tion from those observed in the cohort of BCC or SCC,
and expressed in relation to the number of person-years
at risk [18]. Because smoking prevalence is different for
males and females, we estimated the SIRs and AERs
separately by sex. Data were analysed using SAS release
9.1 (SAS Institute, Cary, NC).
Results
A total of 9,086 SCC and 20,073 BCC cases were
included in this study with mean age at diagnosis being
62.0 and 57.5 years for SCC and BCC respectively. Dur-
ing follow-up through to the end of 2003, 197 subse-
quent lung cancers and 233 other smoking-related
cancers occurred in the SCC patients and 278 lung can-
cers and 391 other smoking-related cancers occurred
among BCC patients. Median follow-up time was 4.13
years for SCC cases and 5.60 years for BCC cases.
People diagnosed with SCC had an increased risk of lung
cancer (SIR = 1.89, 95% CI: 1.61-2.21 for men; SIR = 2.04,
1.42-2.83 for women) and increased risks for all other
smoking-related cancers (SIR = 1.38, 1.19-1.60 for men;
SIR = 1.78, 1.34-2.33 for women) (Table 1). Although there
were relatively fewer cases of smoking-related cancers
among women, a significant association was found.
Among people with BCC, only men had a significantly
increased risk of lung cancer (SIR = 1.26, 1.10-1.44) but
the association with all other smoking-related cancers
was not statistically elevated (SIR = 1.09, 0.97-1.23).
The absolute excess risk (AER) for smoking-related
cancers among SCC cases was greater than for BCC
cases and greater among men than women.
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To our knowledge, this study is the first in Australia to
compare the risk of smoking-related cancers among
people with BCC or SCC with that of the general popu-
lation. Compared with people in the general population,
those with a history of SCC had approximately a two-
fold increased risk of developing lung cancer (and an
AER of 1.98 per 1,000 person-years) and about 40-80%
increased risk of developing all other smoking-related
cancers (and an AER of 1.54 per 1,000 person-years). In
contrast, although men with BCC had a significantly
increased risk of lung cancer compared with that of the
general population, the excess risk was lower than that
for men with SCC.
This is a population-based study with up to 24 years
of follow-up for people of predominately Caucasian ori-
gin with BCC or SCC in a well-defined geographical
region, with minimal variation in UV exposure and mel-
anoma rates. In addition, the fact that all BCC and SCC
and over 80% of subsequent primary cancer diagnoses
were pathologically confirmed [14] reduces potential
misclassification of diagnosis of BCC, SCC or subse-
quent smoking-related cancers.
Our results, suggesting an increased risk of lung can-
cer and other smoking-related cancers among people
with SCC, add to the evidence supporting the associa-
tion between SCC and subsequent smoking-related
cancers. Frisch et al. (1995) first reported, using Dan-
ish Cancer Registry data, that people with SCC were at
higher risk of a subsequent diagnosis of a number of
smoking-related cancers including cancers of the lung,
lip, pharynx, larynx, salivary glands and leukaemia [19].
Increased risks were also found for cancers of the
nasal cavities, penis and vulva/vagina but these did not
reach statistical significance due to small numbers
[19]. Since then this association has been confirmed in
European [20-24] and North American [25-27] popula-
tions and in both registry-based studies [20-25] and
cohort studies [26,27]. A recent systematic review [9]
provided strong and consistent evidence supporting an
association between SCC and lung cancer and indivi-
dual smoking-related cancers of the salivary glands, lip,
mouth and pharynx, and myeloid leukaemia. Our study
is unique in that it is the first study of the association
between SCC and subsequent smoking-related cancers
in the Southern hemisphere, and where the UV index
level is higher (UV index in Tasmania: around 5) than
in most European and North American countries (UV
Index: 1 to 3) where most previous studies were
conducted.
A potential source of bias is that those with a history
of NMSC diagnosis may have had more regular medical
check-ups, particularly after SCC [7], thus increasing the
likelihood of detection of subsequent cancers compared
with the general population. However it is unlikely that
increased detection would be biased towards any parti-
cular cancer type. Another source of bias might be that
we could not exclude prevalent NMSC at the time of
inception of the cohort, however the prevalence for
‘southern’ Australia is expected to be less than 1% [1].
Another limitation is incomplete coverage of BCC and
SCC cases because cases were notified to the TCR only
if the diagnosis had been histologically confirmed or if
the treatment had been provided at one of the two
radiation oncology clinics in the State [28]. However
without histological confirmation, diagnostic certainty of
Table 1 Risk of subsequent smoking-related cancers after non-melanoma skin cancer diagnosed at age 40-74 years in
1980-2003, Tasmania, Australia
Number of observed cases Person-years Standardised Incidence Ratio 95% confidence intervals AER*
SCC
Lung cancer
Men 162 31,612 1.89 1.61-2.21 2.41
Women 35 15,800 2.04 1.42-2.83 1.13
All other smoking-related cancers
Men 179 31,673 1.38 1.19-1.60 1.56
Women 54 15,861 1.78 1.34-2.33 1.49
BCC
Lung cancer
Men 221 77,379 1.26 1.10-1.44 0.60
Women 57 57,431 1.14 0.86-1.47 0.12
All other smoking-related cancers
Men 293 77,455 1.09 0.97-1.23 0.32
Women 98 57,550 1.10 0.89-1.34 0.15
* Absolute excess risk per 1,000 person-years
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dilute any putative associations.
Conclusions
We found that in Tasmania, Australia, people with SCC
had a significantly elevated risk of being diagnosed with
lung cancer and other smoking-related cancers. Risk fac-
tors in common for these two types of cancers, includ-
ing exposure to UV, smoking, and lifestyle factors such
as socioeconomic status, may explain some of the find-
ings. UV exposure is the main risk factor for SCC and
may influence the subsequent cancers such as non-
Hodgkin lymphoma (NHL) and leukaemia through
immunosuppression and reduced DNA repair capacity;
however, NHL is not included in the smoking-related
cancers and leukaemia contributes only a small number
to that group. Incidence rates of SCC in Tasmania vary
by socioeconomic status (A.V. Unpublished data) which
might confound the association between SCC and
smoking-related cancers. However, the association
between smoking and SCC remained after controlling
for several potential confounding factors in a number of
cohort studies [26,27] which indicates that these factors
may not change the main finding of this study. There-
fore, smoking seems the most likely shared aetiological
factor for these conditions. Literature from case control
[5,6] and cohort [7] studies suggest that current smokers
had about three to four-fold increased risk, compared
with never smokers, for developing SCC. Furthermore,
in three studies where a dose response was measured,
the risk of SCC increased in relation to the number of
cigarettes currently smoked and is lower for ex-smokers
[5-7]. The association between smoking and SCC is
therefore well worth investigating in Australia. In the
meanwhile, encouraging individuals with SCC who
s m o k et oq u i ts m o k i n gm a yr e d u c et h er i s ko fs u b s e -
quent smoking-related primary cancer.
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